{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:49:17Z","timestamp":1791218957031,"version":"4.1.0"},"reference-count":43,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/or.2015.3879","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T10:19:57Z","timestamp":1427105997000},"page":"2299-2308","source":"Crossref","is-referenced-by-count":60,"title":["HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells"],"prefix":"10.3892","volume":"33","author":[{"given":"MEIYING","family":"JI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUN JEOUNG","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KI BAE","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YANGMI","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROHYUN","family":"SUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANG-JEON","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DON SOO","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEON MEE","family":"PARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"key20180107213126_b1-or-33-05-2299","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4143\/crt.2012.44.1.11","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009","volume":"44","author":"Jung","year":"2012","journal-title":"Cancer Res Treat"},{"key":"key20180107213126_b2-or-33-05-2299","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jso.21404","article-title":"Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection","volume":"100","author":"Tsai","year":"2009","journal-title":"J Surg Oncol"},{"key":"key20180107213126_b3-or-33-05-2299","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1746-1596-8-99","article-title":"Combined aberrant expression of E-cadherin and S100A4, but not \u03b2-catenin is associated with disease-free survival and overall survival in colorectal cancer patients","volume":"8","author":"Lee","year":"2013","journal-title":"Diagn Pathol"},{"key":"key20180107213126_b4-or-33-05-2299","doi-asserted-by":"crossref","first-page":"e70858","DOI":"10.1371\/journal.pone.0070858","article-title":"Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"key20180107213126_b5-or-33-05-2299","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/cgt.2014.15","article-title":"Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer","volume":"21","author":"Findlay","year":"2014","journal-title":"Cancer Gene Ther"},{"key":"key20180107213126_b6-or-33-05-2299","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/epi.3.1.5736","article-title":"HDACs and HDAC inhibitors in colon cancer","volume":"3","author":"Mariadason","year":"2008","journal-title":"Epigenetics"},{"key":"key20180107213126_b7-or-33-05-2299","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/cbr.2009.0629","article-title":"HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells","volume":"24","author":"Chen","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107213126_b8-or-33-05-2299","first-page":"384","article-title":"The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways","volume":"28","author":"Meng","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107213126_b9-or-33-05-2299","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbagen.2011.11.011","article-title":"Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells","volume":"1820","author":"Hsu","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key20180107213126_b10-or-33-05-2299","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mc.20777","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2\/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells","volume":"51","author":"Xiong","year":"2012","journal-title":"Mol Carcinog"},{"key":"key20180107213126_b11-or-33-05-2299","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1582-4934.2007.00136.x","article-title":"Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis","volume":"12","author":"Habold","year":"2008","journal-title":"J Cell Mol Med"},{"key":"key20180107213126_b12-or-33-05-2299","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/14737140.7.4.583","article-title":"Development of histone deacetylase inhibitors for cancer treatment","volume":"7","author":"Marchion","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107213126_b13-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.24158","article-title":"Valproic acid enhances bosutinib cytotoxicity in colon cancer cells","volume":"124","author":"Mologni","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107213126_b14-or-33-05-2299","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/ol.2012.951","article-title":"The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models","volume":"5","author":"DI Fazio","year":"2013","journal-title":"Oncol Lett"},{"key":"key20180107213126_b15-or-33-05-2299","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-013-2784-7","article-title":"Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin","volume":"143","author":"Shah","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107213126_b16-or-33-05-2299","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1535-7163.MCT-10-0582","article-title":"MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo","volume":"9","author":"Srivastava","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key20180107213126_b17-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jtcvs.2010.01.039","article-title":"Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells","volume":"139","author":"Taylor","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107213126_b18-or-33-05-2299","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2013.10","article-title":"Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2\u2032-deoxycytidine on ovarian cancer","volume":"108","author":"Meng","year":"2013","journal-title":"Br J Cancer"},{"key":"key20180107213126_b19-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.23765","article-title":"Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes","volume":"52","author":"Kaimori","year":"2010","journal-title":"Hepatology"},{"key":"key20180107213126_b20-or-33-05-2299","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jcmm.12212","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells","volume":"18","author":"Xiao","year":"2014","journal-title":"J Cell Mol Med"},{"key":"key20180107213126_b21-or-33-05-2299","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1038\/cddis.2013.416","article-title":"The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Death Dis"},{"key":"key20180107213126_b22-or-33-05-2299","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.2005111187","article-title":"Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells","volume":"18","author":"Yoshikawa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key20180107213126_b23-or-33-05-2299","doi-asserted-by":"crossref","first-page":"e45045","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal tranasition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"key20180107213126_b24-or-33-05-2299","doi-asserted-by":"crossref","first-page":"e58672","DOI":"10.1371\/journal.pone.0058672","article-title":"Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer","volume":"8","author":"Giudice","year":"2013","journal-title":"PLoS One"},{"key":"key20180107213126_b25-or-33-05-2299","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbamcr.2012.12.002","article-title":"Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression","volume":"1833","author":"Jiang","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20180107213126_b26-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/j.gastro.2009.12.010","article-title":"Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180107213126_b27-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180107213126_b28-or-33-05-2299","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2443.2007.01104.x","article-title":"The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression","volume":"12","author":"Wu","year":"2007","journal-title":"Genes Cells"},{"key":"key20180107213126_b29-or-33-05-2299","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.M111.286138","article-title":"Studies using an in vitro model show evidence of involvement of epithelial-mesenchymal transition of human endometrial epithelial cells in human embryo implantation","volume":"287","author":"Uchida","year":"2012","journal-title":"J Biol Chem"},{"key":"key20180107213126_b30-or-33-05-2299","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"key20180107213126_b31-or-33-05-2299","doi-asserted-by":"crossref","first-page":"e10024","DOI":"10.1371\/journal.pone.0010024","article-title":"A system-wide investigation of the dynamics of Wnt signaling reveals novel phases of transcriptional regulation","volume":"5","author":"Gujral","year":"2010","journal-title":"PLoS One"},{"key":"key20180107213126_b32-or-33-05-2299","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.3748\/wjg.v12.i27.4304","article-title":"E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome","volume":"12","author":"Elzagheid","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180107213126_b33-or-33-05-2299","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2353\/ajpath.2010.100079","article-title":"Site-dependent E-cadherin cleavage and nuclear translocation in metastatic colorectal cancer model","volume":"177","author":"C\u00e9spedes","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107213126_b34-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.5858\/2000-124-1147-NLOECE","article-title":"Nuclear localization of E-cadherin expression in Merkel cell carcinoma","volume":"124","author":"Han","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107213126_b35-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5858\/2006-130-1320-DEPOEA","article-title":"Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma","volume":"130","author":"Moon","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107213126_b36-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/labinvest.3700684","article-title":"Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma","volume":"87","author":"Gervais","year":"2007","journal-title":"Lab Invest"},{"key":"key20180107213126_b37-or-33-05-2299","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/modpathol.3800990","article-title":"Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas","volume":"21","author":"Salahshor","year":"2008","journal-title":"Mod Pathol"},{"key":"key20180107213126_b38-or-33-05-2299","first-page":"296","article-title":"Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas","volume":"8","author":"Serra","year":"2007","journal-title":"JOP"},{"key":"key20180107213126_b39-or-33-05-2299","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0046-8177(03)00285-5","article-title":"Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma","volume":"34","author":"Ordonez","year":"2003","journal-title":"Hum Pathol"},{"key":"key20180107213126_b40-or-33-05-2299","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/cncr.25176","article-title":"Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids","volume":"116","author":"Robertson","year":"2010","journal-title":"Cancer"},{"key":"key20180107213126_b41-or-33-05-2299","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2010.05.006","article-title":"Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition","volume":"42","author":"Lei","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107213126_b42-or-33-05-2299","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15563650802178136","article-title":"Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"46","author":"Manoguerra","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"key20180107213126_b43-or-33-05-2299","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2005","journal-title":"Nat Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3879\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T14:27:08Z","timestamp":1651588028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,3,23]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/or.2015.3879"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3879","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}